Kronenfeld Mark A. has filed 10 insider transactions across 1 company since June 2023.
Most recent transaction: a grant/award of 6163 shares of Pacira BioSciences, Inc. ($PCRX) on June 11, 2025.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 11, 2025 | Pacira BioSciences, Inc. | $PCRX | Kronenfeld Mark A. | Director | A | Common Stock | 6163 | $0.00 | 31,065.0000 | 46,245,000 | 24.75% | 0.01% |
| June 11, 2025 | Pacira BioSciences, Inc. | $PCRX | Kronenfeld Mark A. | Director | A | Common Stock | 9999 | $0.00 | 34,901.0000 | 46,245,000 | 40.15% | 0.02% |
| June 11, 2025 | Pacira BioSciences, Inc. | $PCRX | Kronenfeld Mark A. | Director | A | Stock Option (Right to Buy) | 11279 | $0.00 | 11,279.0000 | 46,245,000 | 9999.99% | 0.02% |
| June 12, 2024 | Pacira BioSciences, Inc. | $PCRX | Kronenfeld Mark A. | Director | A | Common Stock | 5230 | $0.00 | 24,902.0000 | 51,979,000 | 26.59% | 0.01% |
| June 12, 2024 | Pacira BioSciences, Inc. | $PCRX | Kronenfeld Mark A. | Director | A | Stock Option (Right to Buy) | 12179 | $0.00 | 12,179.0000 | 51,979,000 | 9999.99% | 0.02% |
| June 14, 2023 | Pacira BioSciences, Inc. | $PCRX | Kronenfeld Mark A. | Director | A | Common Stock | 1775 | $0.00 | 19,672.0000 | 46,538,000 | 9.92% | 0.00% |
| June 14, 2023 | Pacira BioSciences, Inc. | $PCRX | Kronenfeld Mark A. | Director | A | Stock Option (Right to Buy) | 12925 | $0.00 | 12,925.0000 | 46,538,000 | 9999.99% | 0.03% |
| June 8, 2023 | Pacira BioSciences, Inc. | $PCRX | Kronenfeld Mark A. | Director | M | Common Stock | 15000 | $29.90 | 32,897.0000 | 46,538,000 | 83.81% | 0.03% |
| June 8, 2023 | Pacira BioSciences, Inc. | $PCRX | Kronenfeld Mark A. | Director | S | Common Stock | 15000 | $37.04 | 17,897.0000 | 46,538,000 | 45.60% | 0.03% |
| June 8, 2023 | Pacira BioSciences, Inc. | $PCRX | Kronenfeld Mark A. | Director | M | Stock Option (Right to Buy) | 15000 | $0.00 | 0.0000 | 46,538,000 | 100.00% | 0.03% |